甲氨蝶呤联合宫外孕Ⅱ号治疗异位妊娠的临床研究

摘要

目的：探讨甲氨蝶呤(MTX)联合宫外孕Ⅱ号治疗异位妊娠的临床疗效.方法：将180例异位妊娠患者随意分为两组，对照组90例采用静脉推注甲氨蝶呤治疗.治疗组90例在对照组基础上加服宫外孕Ⅱ号治疗.结果：治疗组治愈87例，治愈率为96.6%，对照组治愈74例，治愈率为83.3%，两组比较差异有统计学意义(P<0.05).结论：甲氨蝶呤联合宫外孕Ⅱ号治疗异位妊娠的临床疗效较单用西药治疗疗效好用药时间短，安全性高，值得推广.%Objective:Study on methotrexate(MTX)a joint clinical effect of treating ectopic pregnancy,ectopic pregnancyⅡ.Method:180 cases of ectopic pregnancy patients randomly divided into 2 groups,the control group of 90 cases with intravenous injection of methotrexate treatment. Treatment of 90 cases of treatment,control group Ⅱby taking on the basis of ectopic pregnancy.Result:The treatment cured 87 cases,cure rates for 96.6%,control group heal 74 cases,cure rates for 83.3%,comparison of two groups,the difference has significant meaning(P<0.05).Conclusion:Methotrexate a joint clinical effect of treating ectopic pregnancy,ectopic pregnancy Ⅱcompared with Western medicines alone good therapeutic medication time is short,high safety,merit promotion.